Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for VNDA
| Stock Name | Vanda Pharmaceuticals Inc |
| Ticker | VNDA(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US9216591084 |
| LEI | 529900AY8VOOQBKJ0O70 |
Show aggregate VNDA holdings
News associated with VNDA
- XTX Topco Ltd Has $318,000 Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- XTX Topco Ltd grew its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 378.3% during the first quarter, HoldingsChannel.com reports. The firm owned 69,329 shares of the biopharmaceutical company’s stock after acquiring an additional 54,833 shares during the quarter. XTX Topco Ltd’s holdings in Vanda Pharmaceuticals were worth $318,000 as of […] - 2025-08-11 05:34:58
- Vanda (VNDA) Q2 Revenue Rises 4%
- Key PointsNet loss (GAAP) widened sharply due to increased spending in Q2 2025, with GAAP EPS was ($0.46) for Q2 2025. - 2025-08-01 05:18:57
- GSA Capital Partners LLP Raises Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- GSA Capital Partners LLP increased its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 88.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 260,215 shares of the biopharmaceutical company’s stock after acquiring an additional 121,797 shares during the […] - 2025-07-31 04:29:06
- Public Employees Retirement System of Ohio Has $426,000 Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- Public Employees Retirement System of Ohio reduced its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 16.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 89,032 shares of the biopharmaceutical company’s stock after selling 17,200 shares during the period. Public Employees Retirement System of Ohio […] - 2025-06-05 05:23:00
- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Acquired by Two Sigma Advisers LP
- Two Sigma Advisers LP raised its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 11.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 156,300 shares of the biopharmaceutical company’s stock after acquiring an additional 15,700 shares […] - 2025-06-03 04:56:54
- Short Interest in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Expands By 21.4%
- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 4,880,000 shares, an increase of 21.4% from the March 31st total of 4,020,000 shares. Based on an average daily volume of 663,100 shares, the days-to-cover ratio is currently 7.4 […] - 2025-05-05 02:35:06
- XTX Topco Ltd Makes New Investment in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- XTX Topco Ltd purchased a new position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 14,496 shares of the biopharmaceutical company’s stock, valued at approximately $69,000. A number of other hedge funds also recently modified their holdings of VNDA. Geode Capital Management LLC boosted […] - 2025-05-01 05:28:58
- Geode Capital Management LLC Buys 24,483 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- Geode Capital Management LLC raised its position in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 1.7% in the fourth quarter, HoldingsChannel reports. The fund owned 1,450,310 shares of the biopharmaceutical company’s stock after acquiring an additional 24,483 shares during the period. Geode Capital Management LLC’s holdings in Vanda Pharmaceuticals were worth $6,949,000 […] - 2025-04-25 04:26:50
- Vanguard Group Inc. Has $16.80 Million Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- Vanguard Group Inc. lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 3.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,506,287 shares of the biopharmaceutical company’s stock after selling 125,002 shares during the period. Vanguard Group Inc. owned approximately 0.06% of Vanda Pharmaceuticals worth $16,795,000 as of its most […] - 2025-04-17 04:25:09
- ExodusPoint Capital Management LP Decreases Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- ExodusPoint Capital Management LP trimmed its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 74.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 31,506 shares of the biopharmaceutical company’s stock after selling 94,144 shares during the quarter. ExodusPoint […] - 2025-04-15 04:39:18
- American Century Companies Inc. Raises Stock Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- American Century Companies Inc. increased its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 300,276 shares of the biopharmaceutical company’s stock after acquiring an additional 6,079 shares during the […] - 2025-04-10 04:28:52
- 135,400 Shares in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Bought by KLP Kapitalforvaltning AS
- KLP Kapitalforvaltning AS bought a new stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 135,400 shares of the biopharmaceutical company’s stock, valued at approximately $649,000. KLP Kapitalforvaltning AS owned […] - 2025-04-02 05:16:59
- Bank of New York Mellon Corp Cuts Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
- Bank of New York Mellon Corp lessened its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 14.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 175,017 shares of the biopharmaceutical company’s stock after selling 30,260 shares during the quarter. Bank of New York Mellon Corp’s […] - 2025-03-26 05:12:48
- Reviewing Vanda Pharmaceuticals (NASDAQ:VNDA) & Rapport Therapeutics (NASDAQ:RAPP)
- Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of […] - 2025-03-25 03:36:46
- Vanda Pharmaceuticals (NASDAQ:VNDA) Given New $20.00 Price Target at HC Wainwright
- Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) had its price target upped by HC Wainwright from $18.00 to $20.00 in a research note issued to investors on Tuesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on Vanda Pharmaceuticals in a report on Wednesday, February 5th. […] - 2025-02-19 04:56:52
- Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by StockNews.com
- Analysts at StockNews.com began coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $18.00 price objective on shares of Vanda Pharmaceuticals in a research report […] - 2025-02-07 04:20:53
- Comparing Vanda Pharmaceuticals (NASDAQ:VNDA) & Cyclerion Therapeutics (NASDAQ:CYCN)
- Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Profitability This table compares Vanda Pharmaceuticals and […] - 2025-02-05 04:26:43
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) VNDA holdings
| Date | Number of VNDA Shares Held | Base Market Value of VNDA Shares | Local Market Value of VNDA Shares | Change in VNDA Shares Held | Change in VNDA Base Value | Current Price per VNDA Share Held | Previous Price per VNDA Share Held |
|---|
| 2025-11-11 (Tuesday) | 41,127 | USD 180,136 | USD 180,136 | 0 | USD -1,645 | USD 4.37999 | USD 4.41999 |
| 2025-11-10 (Monday) | 41,127 | USD 181,781 | USD 181,781 | 109 | USD 1,302 | USD 4.41999 | USD 4.4 |
| 2025-11-07 (Friday) | 41,018 | USD 180,479 | USD 180,479 | 0 | USD -410 | USD 4.4 | USD 4.40999 |
| 2025-11-06 (Thursday) | 41,018 | USD 180,889 | USD 180,889 | 109 | USD -747 | USD 4.40999 | USD 4.44 |
| 2025-11-05 (Wednesday) | 40,909 | USD 181,636 | USD 181,636 | 0 | USD 3,682 | USD 4.44 | USD 4.35 |
| 2025-11-04 (Tuesday) | 40,909 | USD 177,954 | USD 177,954 | 109 | USD -4,422 | USD 4.35 | USD 4.47 |
| 2025-11-03 (Monday) | 40,800 | USD 182,376 | USD 182,376 | 0 | USD 4,896 | USD 4.47 | USD 4.35 |
| 2025-10-31 (Friday) | 40,800 | USD 177,480 | USD 177,480 | 545 | USD 3,578 | USD 4.35 | USD 4.32001 |
| 2025-10-30 (Thursday) | 40,255 | USD 173,902 | USD 173,902 | 0 | USD -43,878 | USD 4.32001 | USD 5.41001 |
| 2025-10-29 (Wednesday) | 40,255 | USD 217,780 | USD 217,780 | 218 | USD -5,626 | USD 5.41001 | USD 5.57999 |
| 2025-10-28 (Tuesday) | 40,037 | USD 223,406 | USD 223,406 | 0 | USD -1,202 | USD 5.57999 | USD 5.61001 |
| 2025-10-27 (Monday) | 40,037 | USD 224,608 | USD 224,608 | 0 | USD 4,404 | USD 5.61001 | USD 5.50001 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of VNDA by Blackrock for IE00BDZVHG35
Show aggregate share trades of VNDA| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-10 | BUY | 109 | | | 4.420* | | 4.66 |
| 2025-11-06 | BUY | 109 | | | 4.410* | | 4.66 |
| 2025-11-04 | BUY | 109 | | | 4.350* | | 4.67 |
| 2025-10-31 | BUY | 545 | 4.510 | 4.280 | 4.303 | USD 2,345 | 4.67 |
| 2025-10-29 | BUY | 218 | 5.410 | 5.630 | 5.608 | USD 1,223 | 4.67 |
| 2025-10-22 | SELL | -432 | 5.340 | 5.380 | 5.376 | USD -2,322 | 4.64 Loss of -316 on sale |
| 2025-10-20 | BUY | 214 | 5.330 | 5.450 | 5.438 | USD 1,164 | 4.64 |
| 2025-10-17 | BUY | 538 | 5.270 | 5.310 | 5.306 | USD 2,855 | 4.63 |
| 2025-10-15 | BUY | 848 | 5.380 | 5.400 | 5.398 | USD 4,578 | 4.63 |
| 2025-10-03 | BUY | 763 | 5.430 | 5.480 | 5.475 | USD 4,177 | 4.62 |
| 2025-10-02 | BUY | 109 | 5.160 | 5.220 | 5.214 | USD 568 | 4.62 |
| 2025-09-30 | BUY | 218 | 4.990 | 5.000 | 4.999 | USD 1,090 | 4.61 |
| 2025-09-26 | BUY | 220 | 5.100 | 5.120 | 5.118 | USD 1,126 | 4.61 |
| 2025-09-25 | BUY | 220 | 4.830 | 4.920 | 4.911 | USD 1,080 | 4.61 |
| 2025-09-18 | BUY | 110 | 4.520 | 4.540 | 4.538 | USD 499 | 4.61 |
| 2025-09-17 | BUY | 330 | 4.390 | 4.500 | 4.489 | USD 1,481 | 4.61 |
| 2025-09-11 | SELL | -110 | 4.600 | 4.600 | 4.600 | USD -506 | 4.61 Profit of 1 on sale |
| 2025-09-10 | BUY | 220 | 4.480 | 4.640 | 4.624 | USD 1,017 | 4.61 |
| 2025-07-17 | SELL | -214 | 4.860 | 4.890 | 4.887 | USD -1,046 | 4.61 Loss of -60 on sale |
| 2025-07-11 | SELL | -872 | 4.740 | 5.000 | 4.974 | USD -4,337 | 4.60 Loss of -325 on sale |
| 2025-07-02 | BUY | 5,995 | 4.890 | 4.900 | 4.899 | USD 29,370 | 4.59 |
| 2025-06-25 | BUY | 216 | 4.610 | 4.640 | 4.637 | USD 1,002 | 4.59 |
| 2025-06-11 | BUY | 218 | 4.580 | 4.720 | 4.706 | USD 1,026 | 4.59 |
| 2025-06-10 | BUY | 218 | 4.660 | 4.700 | 4.696 | USD 1,024 | 4.59 |
| 2025-06-04 | SELL | -109 | 4.440 | 4.460 | 4.458 | USD -486 | 4.59 Profit of 15 on sale |
| 2025-04-23 | BUY | 109 | 4.330 | 4.490 | 4.474 | USD 488 | 4.69 |
| 2025-04-10 | SELL | -872 | 4.080 | 4.100 | 4.098 | USD -3,573 | 4.73 Profit of 548 on sale |
| 2025-04-08 | SELL | -109 | 4.140 | 4.300 | 4.284 | USD -467 | 4.74 Profit of 50 on sale |
| 2025-04-07 | SELL | -109 | 4.190 | 4.260 | 4.253 | USD -464 | 4.75 Profit of 54 on sale |
| 2025-04-04 | SELL | -550 | 4.140 | 4.330 | 4.311 | USD -2,371 | 4.75 Profit of 243 on sale |
| 2025-04-01 | BUY | 436 | 4.500 | 4.640 | 4.626 | USD 2,017 | 4.76 |
| 2025-03-31 | SELL | -327 | 4.590 | 4.730 | 4.716 | USD -1,542 | 4.76 Profit of 15 on sale |
| 2025-03-21 | BUY | 4,845 | 4.770 | 4.960 | 4.941 | USD 23,939 | 4.76 |
| 2025-03-14 | SELL | -1,488 | 4.980 | 5.070 | 5.061 | USD -7,531 | 4.75 Loss of -466 on sale |
| 2025-03-07 | SELL | -186 | 4.850 | 5.060 | 5.039 | USD -937 | 4.74 Loss of -56 on sale |
| 2025-03-04 | SELL | -93 | 4.810 | 4.830 | 4.828 | USD -449 | 4.73 Loss of -9 on sale |
| 2025-02-25 | BUY | 186 | 4.460 | 4.500 | 4.496 | USD 836 | 4.73 |
| 2025-02-19 | SELL | -93 | 4.550 | 4.640 | 4.631 | USD -431 | 4.75 Profit of 11 on sale |
| 2025-02-13 | BUY | 279 | 4.700 | 4.800 | 4.790 | USD 1,336 | 4.77 |
| 2025-02-12 | BUY | 93 | 4.750 | 4.780 | 4.777 | USD 444 | 4.77 |
| 2025-02-11 | BUY | 368 | 4.720 | 4.750 | 4.747 | USD 1,747 | 4.77 |
| 2024-12-30 | SELL | -5,840 | 4.780 | 4.900 | 4.888 | USD -28,546 | 4.88 Loss of -68 on sale |
| 2024-11-18 | SELL | -1,650 | 4.980 | 5.070 | 5.061 | USD -8,351 | 4.79 Loss of -441 on sale |
| 2024-11-08 | SELL | -110 | 5.190 | 5.230 | 5.226 | USD -575 | 4.72 Loss of -55 on sale |
| 2024-10-21 | SELL | -111 | 4.730 | 4.930 | 4.910 | USD -545 | 0.00 Loss of -545 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of VNDA
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 42,774 | 2,453 | 131,244 | 32.6% |
| 2025-09-18 | 25,487 | 0 | 103,697 | 24.6% |
| 2025-09-17 | 42,313 | 0 | 99,513 | 42.5% |
| 2025-09-16 | 16,592 | 0 | 110,453 | 15.0% |
| 2025-09-15 | 49,998 | 4,027 | 122,733 | 40.7% |
| 2025-09-12 | 55,842 | 0 | 160,488 | 34.8% |
| 2025-09-11 | 42,447 | 0 | 110,256 | 38.5% |
| 2025-09-10 | 25,113 | 1,000 | 115,790 | 21.7% |
| 2025-09-09 | 31,129 | 446 | 70,773 | 44.0% |
| 2025-09-08 | 28,194 | 0 | 68,400 | 41.2% |
| 2025-09-05 | 27,068 | 0 | 125,697 | 21.5% |
| 2025-09-04 | 113,956 | 17,115 | 231,507 | 49.2% |
| 2025-09-03 | 54,340 | 0 | 112,436 | 48.3% |
| 2025-09-02 | 52,592 | 4,793 | 241,174 | 21.8% |
| 2025-08-29 | 26,190 | 0 | 81,421 | 32.2% |
| 2025-08-28 | 45,898 | 0 | 150,189 | 30.6% |
| 2025-08-27 | 19,368 | 5,600 | 96,935 | 20.0% |
| 2025-08-26 | 52,199 | 200 | 124,704 | 41.9% |
| 2025-08-25 | 40,000 | 199 | 161,310 | 24.8% |
| 2025-08-22 | 45,003 | 0 | 127,801 | 35.2% |
| 2025-08-21 | 57,678 | 0 | 170,952 | 33.7% |
| 2025-08-20 | 22,347 | 0 | 105,692 | 21.1% |
| 2025-08-19 | 55,399 | 203 | 176,148 | 31.5% |
| 2025-08-18 | 188,374 | 11,471 | 480,631 | 39.2% |
| 2025-08-15 | 47,358 | 0 | 111,575 | 42.4% |
| 2025-08-14 | 56,845 | 7 | 138,850 | 40.9% |
| 2025-08-13 | 47,990 | 0 | 178,443 | 26.9% |
| 2025-08-12 | 83,180 | 8,700 | 251,642 | 33.1% |
| 2025-08-11 | 58,803 | 0 | 148,163 | 39.7% |
| 2025-08-08 | 57,309 | 0 | 117,859 | 48.6% |
| 2025-08-07 | 87,919 | 2,763 | 143,066 | 61.5% |
| 2025-08-06 | 139,442 | 3,417 | 252,623 | 55.2% |
| 2025-08-05 | 71,928 | 0 | 173,007 | 41.6% |
| 2025-08-04 | 102,812 | 118 | 269,247 | 38.2% |
| 2025-08-01 | 168,331 | 9,932 | 356,470 | 47.2% |
| 2025-07-31 | 366,630 | 25,169 | 758,404 | 48.3% |
| 2025-07-30 | 101,622 | 19,723 | 407,514 | 24.9% |
| 2025-07-29 | 54,833 | 0 | 160,273 | 34.2% |
| 2025-07-28 | 35,669 | 8,395 | 106,256 | 33.6% |
| 2025-07-25 | 90,519 | 4 | 154,637 | 58.5% |
| 2025-07-24 | 49,307 | 648 | 146,927 | 33.6% |
| 2025-07-23 | 69,319 | 0 | 165,089 | 42.0% |
| 2025-07-22 | 42,768 | 8,190 | 106,058 | 40.3% |
| 2025-07-21 | 51,559 | 500 | 211,909 | 24.3% |
| 2025-07-18 | 52,510 | 10 | 131,904 | 39.8% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.